Safety and efficacy of omecamtiv mecarbil for heart failure: A systematic review and meta-analysis

Safety and efficacy of omecamtiv mecarbil for heart failure: A systematic review and meta-analysis

Aim: To assess the safety and efficacy of omecamtiv mecarbil compared with placebo in heart failure (HF) patients. Methods: We searched PubMed, Web of Science, Cochrane Library, and SCOPUS until August 15th, 2021. We included all randomized controlled studies comparing omecamtiv mecarbil with placeb...

Full description

Bibliographic Details
Main Authors:	Fadel Alqatati, Mohammad Elbahnasawy, Seif Bugazia, Khaled Mohamed Ragab, Ahmed Bostamy Elsnhory, Mostafa Shehata, Sarah Makram Elsayed, Mustafa Ali Fathy, Anas Zakarya Nourelden
Format:	Article
Language:	English
Published:	Elsevier 2022-05-01
Series:	Indian Heart Journal
Subjects:	Omecamtiv mecarbil AMG 423 Heart failure Meta-analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483222000499

Similar Items

Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil
by: Edgardo Kaplinsky, et al.
Published: (2018-04-01)

The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation
by: Bachar El Oumeiri, et al.
Published: (2021-08-01)

Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword
by: Jorik H. Amesz, et al.
Published: (2023-09-01)

Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future
by: Shujing Zhou, et al.
Published: (2024-03-01)

Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil
by: Bachar El Oumeiri, et al.
Published: (2023-01-01)

Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats
by: Bachar El-Oumeiri, et al.
Published: (2018-05-01)

Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels
by: Arnold Péter Ráduly, et al.
Published: (2023-04-01)

Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil
by: Aaron Snoberger, et al.
Published: (2021-02-01)

Cardiac myosin activation in the treatment of congestive heart failure: New therapeutic options and review of literature
by: Arroj Ali, et al.
Published: (2021-01-01)

Characterization of Stimulatory Action on Voltage-Gated Na<sup>+</sup> Currents Caused by Omecamtiv Mecarbil, Known to Be a Myosin Activator
by: Chih-Yu Ting, et al.
Published: (2023-05-01)

Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
by: Shi Shen, et al.
Published: (2021-06-01)

Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy
by: Mohit Kumar, et al.
Published: (2023-01-01)

Tópicos Emergentes em Insuficiência Cardíaca: Perspectivas Futuras
by: Mucio Tavares de Oliveira Jr, et al.
Published: (2021-01-01)

Current Approaches to Worsening Heart Failure: Pathophysiological and Molecular Insights
by: Andrea D’Amato, et al.
Published: (2024-01-01)

Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis
by: Matteo Pagnesi, et al.
Published: (2022-01-01)

Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
by: Daniela Tomasoni, et al.
Published: (2022-06-01)

Recent and Upcoming Drug Therapies for Pediatric Heart Failure
by: Karla L. Loss, et al.
Published: (2021-11-01)

Allosteric modulation of cardiac myosin dynamics by omecamtiv mecarbil.
by: Shaima Hashem, et al.
Published: (2017-11-01)

La Encefalitis de St. Louis
by: Jorge Rey
Published: (2002-11-01)

Orthophosphate increases the efficiency of slow muscle-myosin isoform in the presence of omecamtiv mecarbil
by: Serena Governali, et al.
Published: (2020-07-01)

Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
by: Vicente J. Planelles-Herrero, et al.
Published: (2017-08-01)

Transient receptor potential melastatin 8 (TRPM8) channels are involved in body temperature regulation
by: Gavva Narender R, et al.
Published: (2012-05-01)

Effects of omecamtiv mecarbil on the contractile properties of skinned porcine left atrial and ventricular muscles
by: Tomohiro Nakanishi, et al.
Published: (2022-08-01)

2003 Handbook of Employment Regulations Affecting Florida Farm Employers and Workers: Workers' Compensation [State]
by: Leo C. Polopolus, et al.
Published: (2003-07-01)

Sipò Pou Do-Kay
by: Hal S. Knowles, III, et al.
Published: (2007-08-01)

Micronutrient Deficiencies in Citrus: Iron, Zinc, and Manganese
by: Mongi Zekri, et al.
Published: (2003-01-01)

Research Needs and Logistic Impediments in Restoration, Enhancement, and Management Projects: A Survey of Land Managers
by: Carrie R. Adams, et al.
Published: (2010-07-01)

Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working stroke
by: Michael S. Woody, et al.
Published: (2018-09-01)

Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy.
by: Johan Lindqvist, et al.
Published: (2019-01-01)

Myosin activator omecamtiv mecarbil exhibits divergent inotropic and lusitropic effects in cardiac slices from patients with heart failure
by: Fahimeh Varzideh, et al.
Published: (2023-09-01)

Protecting Florida Panthers by Protecting Domestic Animals: Building a "Panther-Proof" Pen
by: Phillip D. Rodgers, et al.
Published: (2016-11-01)

Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress
by: Timpika Chaiprasert, et al.
Published: (2019-07-01)

Auxiliary Metabolic Gene Functions in Pelagic and Benthic Viruses of the Baltic Sea
by: Benedikt Heyerhoff, et al.
Published: (2022-07-01)

Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
by: Masataka Kawana, et al.
Published: (2022-09-01)

Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
by: Frontiers Production Office
Published: (2022-12-01)

Use of acoustic myography to evaluate forelimb muscle function in retriever dogs carrying different mouth weights
by: Melissa A. Weber, et al.
Published: (2022-11-01)

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
by: Toshifumi Hibi, et al.
Published: (2019-07-01)

Şanghay İşbirliği Örgütü Ülkelerinde Makroekonomik Göstergelerin İhracat Rekabet Gücüne Etkisi
by: Oğuz Kara, et al.
Published: (2020-09-01)

Hsa-MiR-423 Rs6505162 Is Associated With The Increased Risk Of Breast Cancer In Isfahan Central Province Of Iran
by: Nadia Pourmoshir, et al.
Published: (2020-09-01)

Genome Analysis of Two Novel <i>Synechococcus</i> Phages That Lack Common Auxiliary Metabolic Genes: Possible Reasons and Ecological Insights by Comparative Analysis of Cyanomyoviruses
by: Tong Jiang, et al.
Published: (2020-07-01)